Bluepha Co., Ltd. is an innovative synthetic biology company founded in 2016, dedicated to the research, development, production, and application of polyhydroxyalkanoates (PHA), a fully biodegradable and biocompatible material. Positioned as a sustainable alternative to petroleum-based plastics, Bluepha aims to address the global plastic pollution crisis by leveraging cutting-edge biotechnology to create bio-based materials for a circular economy. Their core technology involves microbial fermentation to produce PHA, with applications spanning packaging, consumer goods, agriculture, and medical fields.
Core R&D, corporate strategy, intellectual property management, and global business development for its innovative PHA biopolymer solutions.
State-of-the-art synthetic biology laboratories, advanced fermentation and polymer analysis equipment, pilot-scale R&D facilities, and collaborative workspaces designed to accelerate innovation in sustainable materials.
A dynamic, research-driven environment fostering innovation and collaboration among scientists, engineers, and business professionals. Strong emphasis on scientific rigor, sustainability, and achieving breakthroughs in bioplastic technology.
The intellectual and strategic core of Bluepha, driving the discovery, development, and commercialization strategy of its PHA technology to address global plastic pollution. It's where foundational research and key decisions are made.
Bluepha's primary operations, including R&D and large-scale manufacturing, are currently concentrated in China. However, its mission to combat plastic pollution with PHA bioplastics has global implications. The company actively participates in international conferences, seeks global partnerships, and its products are designed for a worldwide market addressing universal sustainability goals. While direct international offices are not widely publicized, their strategic intent includes global market penetration.
Life Science Park, Changping District (Specific building details may vary, e.g., Building C9 or No.9 Life Park Road)
Beijing
Beijing
China
Address: Yancheng Economic and Technological Development Zone, Jiangsu Province, China (Specific street address not publicly detailed)
Serves as the main industrial production base, leveraging regional manufacturing infrastructure and support to enable cost-effective, high-volume PHA production for domestic and potentially international markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Bluepha' leadership includes:
Bluepha has been backed by several prominent investors over the years, including:
No major public announcements regarding executive hires or exits at Bluepha have been identified in the last 12 months. The company has been focused on scaling its production capabilities and R&D, suggesting stability and continuity in its core leadership team during this period.
Discover the tools Bluepha uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Bluepha's specific email format is not publicly confirmed. Common corporate email patterns for tech companies, including those in China, often use combinations of first name, last name, or initials. For Pinyin names, variations are also common.
Likely formats include [firstinitial][lastname]@bluepha.com (e.g., jdoe@bluepha.com) or [firstname].[lastname]@bluepha.com (e.g., jane.doe@bluepha.com). For Pinyin names: [pinyin_lastname][pinyin_firstname_initial]@bluepha.com or [pinyin_firstname].[pinyin_lastname]@bluepha.com.
Format
lteng@bluepha.com (speculative example based on Li Teng)
Example
60%
Success rate
SynBioBeta • January 25, 2023
Bluepha detailed significant progress in the construction of its PHA 'super-factory' in Yancheng, China. The facility's initial phase is planned for an annual capacity of 5,000 tons, with aims to expand to 25,000 tons, marking a key step in scaling up production of its biodegradable PHA materials....more
BioMarket Insights • May 8, 2023
This article highlights Bluepha's significant fundraising achievements, exceeding $100 million from prominent investors. It underscores the company's mission to produce PHA bioplastics at scale as a sustainable alternative to conventional plastics, with its Yancheng factory being a cornerstone of this strategy....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Bluepha, are just a search away.